Summary of Coronavirus Disease 2019 Hospitalization and Death Rates and Proportions of Inpatient Complications
Summary . | General Elderly Population (n = 25 333 329) . | Elderly NH Population (n = 653 966) . | ESRD Population (n = 292 302) . |
---|---|---|---|
Age, median, y | 73 | 85 | 65 |
Sex, no. (%) | |||
Female | 14 095 346 (55.6) | 437 379 (66.9) | 127 180 (43.5) |
Male | 11 237 983 (44.4) | 216 587 (33.1) | 165 122 (56.5) |
Severe COVID-19 outcome, no. (rate per 10 000) | |||
COVID-19–related deaths | 12 613 (5.0) | 18 028 (275.7) | 1777 (60.8) |
COVID-19–related hospitalizations | 27 961 (11.0) | 19 637 (300.3) | 4503 (154.1) |
Hospitalization-related outcomes, no. (% of hospitalized) | |||
ICU/CCU admission | 6132 (21.9) | 4719 (24.0) | 1184 (26.3) |
Ventilator use/ECMO | 4646 (16.6) | 2946 (15.0) | 842 (18.7) |
Inpatient renal replacement therapy | 985 (3.5) | 1529 (7.8) | 3744 (83.1) |
Inpatient death | 7 286 (26.1) | 6996 (35.6) | 1135 (25.2) |
Summary . | General Elderly Population (n = 25 333 329) . | Elderly NH Population (n = 653 966) . | ESRD Population (n = 292 302) . |
---|---|---|---|
Age, median, y | 73 | 85 | 65 |
Sex, no. (%) | |||
Female | 14 095 346 (55.6) | 437 379 (66.9) | 127 180 (43.5) |
Male | 11 237 983 (44.4) | 216 587 (33.1) | 165 122 (56.5) |
Severe COVID-19 outcome, no. (rate per 10 000) | |||
COVID-19–related deaths | 12 613 (5.0) | 18 028 (275.7) | 1777 (60.8) |
COVID-19–related hospitalizations | 27 961 (11.0) | 19 637 (300.3) | 4503 (154.1) |
Hospitalization-related outcomes, no. (% of hospitalized) | |||
ICU/CCU admission | 6132 (21.9) | 4719 (24.0) | 1184 (26.3) |
Ventilator use/ECMO | 4646 (16.6) | 2946 (15.0) | 842 (18.7) |
Inpatient renal replacement therapy | 985 (3.5) | 1529 (7.8) | 3744 (83.1) |
Inpatient death | 7 286 (26.1) | 6996 (35.6) | 1135 (25.2) |
Abbreviations: CCU, coronary care unit; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ESRD, end-stage renal disease; ICU, intensive care unit; NH, nursing home.
Summary of Coronavirus Disease 2019 Hospitalization and Death Rates and Proportions of Inpatient Complications
Summary . | General Elderly Population (n = 25 333 329) . | Elderly NH Population (n = 653 966) . | ESRD Population (n = 292 302) . |
---|---|---|---|
Age, median, y | 73 | 85 | 65 |
Sex, no. (%) | |||
Female | 14 095 346 (55.6) | 437 379 (66.9) | 127 180 (43.5) |
Male | 11 237 983 (44.4) | 216 587 (33.1) | 165 122 (56.5) |
Severe COVID-19 outcome, no. (rate per 10 000) | |||
COVID-19–related deaths | 12 613 (5.0) | 18 028 (275.7) | 1777 (60.8) |
COVID-19–related hospitalizations | 27 961 (11.0) | 19 637 (300.3) | 4503 (154.1) |
Hospitalization-related outcomes, no. (% of hospitalized) | |||
ICU/CCU admission | 6132 (21.9) | 4719 (24.0) | 1184 (26.3) |
Ventilator use/ECMO | 4646 (16.6) | 2946 (15.0) | 842 (18.7) |
Inpatient renal replacement therapy | 985 (3.5) | 1529 (7.8) | 3744 (83.1) |
Inpatient death | 7 286 (26.1) | 6996 (35.6) | 1135 (25.2) |
Summary . | General Elderly Population (n = 25 333 329) . | Elderly NH Population (n = 653 966) . | ESRD Population (n = 292 302) . |
---|---|---|---|
Age, median, y | 73 | 85 | 65 |
Sex, no. (%) | |||
Female | 14 095 346 (55.6) | 437 379 (66.9) | 127 180 (43.5) |
Male | 11 237 983 (44.4) | 216 587 (33.1) | 165 122 (56.5) |
Severe COVID-19 outcome, no. (rate per 10 000) | |||
COVID-19–related deaths | 12 613 (5.0) | 18 028 (275.7) | 1777 (60.8) |
COVID-19–related hospitalizations | 27 961 (11.0) | 19 637 (300.3) | 4503 (154.1) |
Hospitalization-related outcomes, no. (% of hospitalized) | |||
ICU/CCU admission | 6132 (21.9) | 4719 (24.0) | 1184 (26.3) |
Ventilator use/ECMO | 4646 (16.6) | 2946 (15.0) | 842 (18.7) |
Inpatient renal replacement therapy | 985 (3.5) | 1529 (7.8) | 3744 (83.1) |
Inpatient death | 7 286 (26.1) | 6996 (35.6) | 1135 (25.2) |
Abbreviations: CCU, coronary care unit; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ESRD, end-stage renal disease; ICU, intensive care unit; NH, nursing home.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.